نتایج جستجو برای: antiemetic

تعداد نتایج: 1483  

Journal: :Supportive Care in Cancer 2010

Journal: :Anaesthesia and Intensive Care 2004

Xylazine hydrochloride, α2 adrenoceptor agonist, is an analgesic, sedative, tranquilizer, and muscle relaxant agent in veterinary medicine which is mostly used as in pre-anesthesia in veterinary medicine. One of the main adverse effects of xylazine which limits application of this medication in small animal veterinary practice (mostly in cats) is nausea and vomiting which can end up with aspira...

Journal: :The journal of supportive oncology 2010
David G Frame

Chemotherapy-induced nausea and vomiting (CINV) involves multiple neurotransmitter and receptor systems; thus, its optimal treatment is likely to require a combination of therapies targeting multiple systems. Antiemetic regimens have evolved from use of dopamine antagonists alone to combination regimens such as a corticosteroid plus an antagonist of the serotonin (5-hydroxytryptamine) type 3 re...

Journal: :Therapeutics and Clinical Risk Management 2008
Ian N Olver

Chemotherapy-induced nausea and vomiting (CINV) remains a challenge in cancer care. Improved understanding of CINV pathophysiology has triggered the development of new antiemetic therapeutic options, such as selective neurokinin-1 (NK1) receptor antagonists (RAs), which effectively prevent CINV when added to a standard antiemetic regimen (serotonin-3 RA and dexamethasone). Aprepitant and its wa...

2017
Signe Ladegaard Harder Jørn Herrstedt

Chemotherapy induced nausea and vomiting (CINV) are two of the most feared adverse events experienced by cancer patients undergoing chemotherapy. Metoclopramide was derived from procainamide in the 1950s and one of the first drugs investigated in the prophylaxis of nausea and vomiting induced by chemotherapy. The breakthrough came in 1981 with the recognition that high-dose metoclopramide was e...

Journal: :Onkologie 2009
Jørn Herrstedt

addition of the NK1-receptor antagonist, casopitant (day 1–3), to a combination of ondansetron (day 1–3) plus dexamethasone (day 1) was investigated in patients receiving moderately emetogenic chemotherapy [4]. In a subpopulation (n = 123) treated with oxaliplatin-based chemotherapy, the 0–120-h complete response rate (no emesis and no need for rescue antiemetics) was improved from approximatel...

2014
Saeed Kolahian

Xylazine hydrochloride, α2 adrenoceptor agonist, is an analgesic, sedative, tranquilizer, and muscle relaxant agent in veterinary medicine which is mostly used as in pre-anesthesia in veterinary medicine. One of the main adverse effects of xylazine which limits application of this medication in small animal veterinary practice (mostly in cats) is nausea and vomiting which can end up with aspira...

2016
Hitoshi Kusaba Hozumi Kumagai Kyoko Inadomi Tomoya Matsunobu Katsumi Harimaya Kotoe Takayoshi Shuji Arita Hiroshi Ariyama Koichi Akashi Eishi Baba

Appropriate antiemetic prophylaxis for moderately emetogenic chemotherapy in patients with non-round cell soft-tissue sarcomas (NRC-STS) remains unclear. We retrospectively investigated efficacy and safety of aprepitant-combined antiemetic prophylaxis in patients with NRC-STS receiving adriamycin plus ifosfamide (AI) therapy. Forty NRC-STS patients were enrolled, their median age was 50 years (...

2013
Amalia S Lehmann Jamie L Renbarger Catherine L McCormick Ariel R Topletz Carrie Rouse David M Haas

BACKGROUND Nausea and vomiting of pregnancy (NVP) is a common condition. The objective of this study was to evaluate the association between response to antiemetics in the treatment of NVP and genetic polymorphisms in the serotonin receptor subunit genes HTR3A and HTR3B. METHODS Pregnant women ≥18 years of age with NVP starting antiemetic therapy with promethazine, prochlorperazine, metoclopr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید